IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Pivotal bioVenture Partners Investment Advisor LLC

Q1 2021 Holdings

Filed 2021-05-14 | 9 holdings | $16.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arcutis Biotherapeutics Inc(ARQT)COM03969K108$16.5M569,04198.2%
Karuna Therapeutics IncCOM48576A100$109.3K908,7080.7%
Bolt Biotherapeutics Inc(BOLT1EUR)COM097702104$62.2K1,891,4670.4%
Inozyme Pharma IncCOM45790W108$31.5K1,591,1540.2%
Vaxcyte Inc(PCVX)COM92243G108$27.8K1,405,4210.2%
Akouos IncCOM00973J101$24.9K1,794,0880.1%
Aligos Therapeutics IncCOM01626L105$19.9K876,5480.1%
Fusion Pharmaceuticals IncCOM36118A100$17.1K1,598,3790.1%
Entasis Therapeutics Hldgs ICOM293614103$2.5K1,176,3780.0%